LMMRX
Price
$30.34
Change
+$0.16 (+0.53%)
Updated
Jul 3 closing price
Net Assets
8.65B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LMMRX vs VVIAX

Header iconLMMRX vs VVIAX Comparison
Open Charts LMMRX vs VVIAXBanner chart's image
ClearBridge Dividend Strategy R
Price$30.34
Change+$0.16 (+0.53%)
VolumeN/A
Net Assets8.65B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LMMRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMMRX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMMRX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. LMMRX (8.65B). VVIAX pays higher dividends than LMMRX: VVIAX (2.18) vs LMMRX (0.87). LMMRX was incepted earlier than VVIAX: LMMRX (13 years) vs VVIAX (25 years). LMMRX (1.35) is less costly to investors than VVIAX (0.05). LMMRX is a more actively managed with annual turnover of: 19.00 vs. VVIAX (9.00). LMMRX has a lower initial minimum investment than VVIAX: LMMRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. LMMRX (4.52). VVIAX return over 5 years is better than : 80.13 vs. LMMRX (39.09).
LMMRXVVIAXLMMRX / VVIAX
Total Expense Ratio1.350.052,700%
Annual Report Gross Expense Ratio1.350.052,700%
Fund Existence13 years25 years-
Gain YTD3.8876.19863%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.65B189B5%
Annual Yield % from dividends0.872.1840%
Returns for 1 year4.5212.0338%
Returns for 3 years17.1335.1749%
Returns for 5 years39.0980.1349%
Returns for 10 years67.76115.6759%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYRG188.885.60
+3.06%
MYR Group
BOLT5.920.01
+0.17%
Bolt Biotherapeutics Inc
PGY22.16-0.02
-0.09%
Pagaya Technologies Ltd
OMC74.71-0.31
-0.41%
Omnicom Group
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc